Researchers at the University of Colorado Anschutz Medical Campus studying interactions between nerves and tumor microenvironments have found that commonly used drugs like botox may stop or slow the progression of certain ...
Feb 28, 2024
0
36
One of the immune system's primary roles is to detect and kill cells that have acquired cancerous mutations. However, some early-stage cancer cells manage to evade this surveillance and develop into more advanced tumors.
Feb 28, 2024
0
62
When foreign antigens trigger an immune response, T cells respond by proliferating and differentiating into two groups—effector and memory cells. Epigenetic and transcriptional pathways mediate this response, but the cells ...
Feb 28, 2024
0
0
Head and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects the mucous membranes of the mouth, nose, and throat. HNSCC is typically associated with tobacco exposure, alcohol abuse, and viral infections. ...
Feb 27, 2024
0
0
Newly published research from an international consortium led by the University of Minnesota's Masonic Cancer Center has the potential to transform the landscape of ovarian cancer treatment.
Feb 27, 2024
0
37
The colon is often thought of as one organ, but the right and left parts of the colon have different molecular features in cancers. New research in mice from investigators at the Johns Hopkins Kimmel Cancer Center demonstrates ...
Feb 27, 2024
0
32
A study by a scientific team from the University of Vienna and the MedUni Vienna, recently published in Cellular & Molecular Immunology, shows that the enzyme phosphoglycerate dehydrogenase (PHGDH) acts as a metabolic checkpoint ...
Feb 27, 2024
0
42
A new research paper titled "GZ17-6.02 interacts with bexarotene to kill mycosis fungoides cells" has been published in Oncotarget.
Feb 27, 2024
0
1
Researchers at the Technion's Ruth and Bruce Rappaport Faculty of Medicine and the Rappaport Family Institute for Research in the Medical Sciences have discovered a subset of blood cells that predict the success of immunotherapy ...
Feb 26, 2024
0
52
Regardless of socioeconomic factors and tumor variables, Black women with triple negative breast cancer have a significantly poorer response to chemotherapy than white women, researchers at Duke Cancer Institute report.
Feb 26, 2024
0
0
